Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.
USD 29.95
Information on this company is supplied by EMIS which is part of Euromoney Institutional Investor plc, one of Europe's largest publishers and a constituent of the FTSE 250 index.

Contact Information

Legal Address
Bafna Towers,, New No. 68, Old No. 299,    , Thambu Chetty Street
Chennai; Tamil Nadu; Map
Postal Code: 600001
Tel: 25267517/ 4267
Fax: 2527

Full name: Bafna Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 2401582
IN-CIN: L24294TN1995PLC030698
ISIN: INE878I01014
Incorporation Date: 1995

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

Capsules, Syrups, Injections, Tablets,

Company Description

Bafna Pharmaceuticals Limited engages in the manufacture and sale of pharmaceutical products. The company offers its products in various therapeutic areas, including anti-bacterials, anti-pyretics, antconvulsants, anxiolytics, pain management, anthelmintics, anti-fungal, appetite stimulants, antidiarrhoeals, antiemetics, hypnotics, antacids and anti-ulcerants, vitamin and dietary preparations, cough and cold preparations, anti-asthmatics, calcium preparations, anti-hypertensives, and anti-diabetics. Bafna…


Basic Information

Total Employees:
Outstanding Shares:
: ()
Registered Capital:
Financial Auditors:

EMIS Benchmark Score

Quote Chart

Quote Summary

Last Price 32.00
Volume 19,706
Turnover 635,026
Market Bombay Stock Exchange
Ticker 532989
Market Cap Market Cap 725,003
52 Week High 50.45
52 Week Low 27.00
Price to Earnings (P/E) -4.79
Earnings per Share (EPS) -7.52
Dividend Yield
Bookvalue 390,600
Enterprise Value 1,335,498
Quote updated on October 21, 2016
Note: data in INR Thousands.


2014: Imports INR 23,746.31 Thousands
Import connections ('000)
2014: Exports INR 359.18 Thousands
Export connections ('000)

Key Executives

Company Secretary

Ownership Details

General Public

Key Stats

Select Items to chart them. 2017 Q1
Net sales revenue
Total operating revenue
Operating profit (EBIT)
Net Profit (Loss)
Total assets N/A
Total equity
Operating Profit (EBIT) Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to Equity
Quick Ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.


Competitors - India


EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Payment methods include:
USD 29.95
Most recent financial data: 2016
Payment methods include:
The full report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS company profiles are part of a larger information service that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest